Linike Medical Group Balance Sheet

Financials in millions USD. Fiscal year is November - October.

Millions USD. Fiscal year is Nov - Oct.

Fiscal Year	TTM	FY 2013	FY 2012
Period Ending	Jul '14 Jul 31, 2014	Oct '13 Oct 31, 2013	Oct '12 Oct 31, 2012
Cash & Equivalents	0	0	0
Cash & Short-Term Investments	0	0	0
Cash Growth	-93.39%	30.21%	-
Prepaid Expenses	-	0	0.01
Total Current Assets	0	0.01	0.01
Total Assets	0	0.01	0.01
Accounts Payable	0.16	0.13	0.02
Other Current Liabilities	0.37	0.36	0.04
Total Current Liabilities	0.53	0.49	0.07
Total Liabilities	0.53	0.49	0.07
Common Stock	0.02	0.02	0
Retained Earnings	-0.58	-0.5	-0.06
Comprehensive Income & Other	0.03	0.01	0
Total Common Equity	-0.53	-0.48	-0.05
Shareholders' Equity	-0.53	-0.48	-0.05
Total Liabilities & Equity	0	0.01	0.01
Net Cash (Debt)	0	0	0
Net Cash Growth	-93.39%	30.21%	-
Net Cash Per Share	0.00	0.00	0.01
Filing Date Shares Outstanding	3.47	3.47	0.27
Total Common Shares Outstanding	3.47	3.47	0.27
Working Capital	-0.53	-0.48	-0.05
Book Value Per Share	-0.15	-0.14	-0.20
Tangible Book Value	-0.53	-0.48	-0.05
Tangible Book Value Per Share	-0.15	-0.14	-0.20

Updated Sep 15, 2014. Source: S&P Global Market Intelligence. Standard template. Financial Sources.